PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity.
Gao J, Kou G, Wang H, Chen H, Li B, Lu Y, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhao J, Zhong Y, Guo Y.
Gao J, et al. Among authors: dai j.
Breast Cancer Res Treat. 2009 May;115(1):29-41. doi: 10.1007/s10549-008-0043-0. Epub 2008 May 15.
Breast Cancer Res Treat. 2009.
PMID: 18481173